Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > ps..

<< Previous

Bullboard Posts

Next >>

Comment by DeathXray33on Oct 30, 2024 8:58pm

232 Views

Post# 36289844

RE:RE:RE:ps..

chry200030 wrote: I think you're right... the bottom is IN.
We will get confirmation tomorrow...
Expect a nice day tomorrow if we get liftoff...

"Rutherrin has been proven preclinically to be activated by Metformin, a common diabetes drug, without the use of light and/or radiation. Even more interesting is that because Rutherrin and Metformin are both scientifically proven to cross the blood-brain barrier, as well as tumour-specific blood barriers, this new discovery potentially allows the precise targeting of cancer cells by Rutherrin anywhere inside the body, including the brain, followed by their synergistic activation by Metformin."

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant